Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis
Leptin, the ob gene product, has been proposed as a mediator of inflammatory cytokine—dependent decreased food intake and cachexia in rodents. In humans, leptin serum levels increase after administration of tumor necrosis factor-alpha (TNF-α) or interleukin-2 or during septicemia. However, the effec...
Saved in:
Published in | Metabolism, clinical and experimental Vol. 48; no. 6; pp. 745 - 748 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.06.1999
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Leptin, the
ob gene product, has been proposed as a mediator of inflammatory cytokine—dependent decreased food intake and cachexia in rodents. In humans, leptin serum levels increase after administration of tumor necrosis factor-alpha (TNF-α) or interleukin-2 or during septicemia. However, the effect of human chronic inflammatory disease on serum leptin is unknown. We therefore determined the serum leptin level (radioimmunoassay), body mass index (BMI), percent body fat ([%BF] bioelectrical impedance analysis), and disease activity (Disease Activity Score [DAS]) in 58 patients with rheumatoid arthritis (RA) and 16 controls. The BMI, %BF, serum leptin, and ratio of leptin to %BF (leptin/%BF) did not differ significantly in 25 patients with moderate RA activity (DAS, 3.6 ± 0.5), 33 patients with low RA activity (DAS, 1.8 ± 0.5), and controls. A positive correlation for serum leptin and %BF was detected in all groups. Our data indicate that in RA, a human chronic cytokine-mediated inflammatory disease, the serum leptin level is directly related to %BF but not to disease activity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0026-0495 1532-8600 |
DOI: | 10.1016/S0026-0495(99)90174-9 |